 She cited studies that highlighted the risks that the drug poses, as well as methodological concerns such as a lack of diversity in clinical trials.On November 14, 2012, Zuckerman made a statement at a Capitol Hill press conference about the VALID Compounding Act.She stated that loopholes in the FDA law, including compounding pharmacies, have allowed hundreds of people to get sick with meningitis and several to die.